4 recruiting, 2 completed, 1 not yet recruiting. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Recruiting 1 |
Follow Ciceri Fabio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Unraveling Dynamics and Clinical Impact of Tregs in Allogeneic HSCT With PTCy HSCT | Not yet recruiting | Ciceri Fabio | 70 | 2026-11-01 | 2026-10-20 | |
| ATLG Levels in Autologous HSCT for Multiple Sclerosis ATLG administration - Multiple Sclerosis, Autologous Hematopoietic Stem Cell Transplant | Recruiting | Ciceri Fabio | 20 | 2026-05-04 | 2026-06-09 | |
| A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma diet rich in fiber - Smoldering Multiple Myeloma (SMM) | Not applicable | Recruiting | Ciceri Fabio | 62 | 2025-10-31 | 2026-04-03 |
| Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia Clinical Practice - Acute Myeloid Leukemia | Recruiting | Ciceri Fabio | 80 | 2025-02-22 | 2026-06-08 | |
| Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways Observations on Relapsed AML Allogeneic Transplanted patients - Acute Myeloid Leukemia, in Relapse | Recruiting | Ciceri Fabio | 500 | 2022-07-18 | 2025-05-13 | |
| Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole Conditioning treatment "Thiotepa-Treosulfan-Fludarabine", PBSC graft, GvHD prophylaxis - Transplant-Related Hematologic Malignancy, Leukemia, Acute | Phase 2 | Completed | Ciceri Fabio | 10 | 2018-06-18 | 2022-07-19 |
| Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant Fludarabine, ARA-C, Treosulfan - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Completed | Ciceri Fabio | 15 | 2009-02-10 | 2023-11-18 |
Leukemia, Myeloid, Acute (3) · Graft vs Host Disease (2) · Leukemia (2) · Myelodysplastic Syndromes (2) · Inflammation (1) · Multiple Sclerosis (1) · Mycoses (1) · Smoldering Multiple Myeloma (1)
Cytarabine (1) · Dietary Fiber (1) · Peripheral Blood Stem Cell Transplantation (1) · fludarabine (1) · treosulfan (1)
Italy (7)
Fabio Ciceri, MD (2)
2008 (1), 2017 (1)